Evidence map›Paper›PMID 21818288›Full record

ArticlePloS one2011

Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus.

Jim E Cutler, Miriam Corti, Patrick Lambert, Michael Ferris, Hong Xin

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Associations Between Candida andMicroorganisms · 2025
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Antifungal Drugs.Metabolites · 2020
    Review
  10. Review
  11. Article
  12. Article
  13. Vaccine immunity against fungal infections.Current opinion in immunology · 2014
    Review
  14. Article
  15. Article
  16. Recent progress in vaccines against fungal diseases.Current opinion in microbiology · 2012
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jim E CutlerDepartment of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America. jcutler@chnola-research.org
Miriam Corti
Patrick Lambert
Michael Ferris
Hong Xin
Louisiana State University Health Sciences Center New Orleans · USChildren's Hospital of New Orleans · US

Funding

Mycology Research Unit: In Vivo Induced Fungal AntigensP01AI061537 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WINGARD, JOHN R. · 2004 to 2008
$3.7M
NIAID NIH HHS P01 AI061537
6 · The paper itself

Abstract

Disseminated candidiasis is the third leading nosocomial blood stream infection in the United States and is often fatal. We previously showed that disseminated candidiasis was preventable in normal mice by immunization with either a glycopeptide or a peptide synthetic vaccine, both of which were Candida albicans cell wall derived. A weakness of these studies is that, unlike humans, mice do not have a C. albicans GI flora and they lack Candida serum antibodies. We examined the influence of C. albicans GI tract colonization and serum antibodies on mouse vaccination responses to the peptide, Fba, derived from fructose bisphosphate aldolase which has cytosolic and cell wall distributions in the fungus. We evaluated the effect of live C. albicans in drinking water and antimicrobial agents on establishment of Candida colonization of the mouse GI tract. Body mass, C. albicans in feces, and fungal-specific serum antibodies were monitored longitudinally. Unexpectedly, C. albicans colonization occurred in mice that received only antibiotics in their drinking water, provided that the mice were housed in the same room as intentionally colonized mice. The fungal strain in unintentionally colonized mice appeared identical to the strain used for intentional GI-tract colonization. This is the first report of horizontal transmission and spontaneous C. albicans colonization in mice. Importantly, many Candida-colonized mice developed serum fungal-specific antibodies. Despite the GI-tract colonization and presence of serum antibodies, the animals made antibodies in response to the Fba immunogen. This mouse model has potential for elucidating C. albicans horizontal transmission and for exploring factors that induce host defense against disseminated candidiasis. Furthermore, a combined protracted GI-tract colonization with Candida and the possibility of serum antibody responses to the presence of the fungus makes this an attractive mouse model for testing the efficacy of vaccines designed to prevent human disseminated candidiasis.

Indexed as

Disease Transmission, InfectiousAnimalsAnti-Bacterial AgentsAntibodies, FungalAntibody FormationCandida albicansCandidiasisColony Count, MicrobialFungal VaccinesGastrointestinal TractHumansMiceMice, Inbred C57BLPilot ProjectsVaccinationAnti-Bacterial AgentsAntibodies, FungalFungal Vaccines

Identifiers

PMID21818288
PMCPMC3139608
OpenAlexW1993532350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.